Skip to main content

Advertisement

Table 6 Addition of C-reactive protein and biventricular volume to model selected for cardiovascular disease mortality

From: Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study

Trait Hazard Ratio 95 % Hazard Ratio Confidence Interval p-value Trait Hazard Ratio 95 % Hazard Ratio Confidence Interval p-value Trait Hazard Ratio 95 % Hazard Ratio Confidence Interval p-value
Age 1.36 1.08 1.73 0.010 Age 1.63 1.27 2.10 1.20 × 10−4 Age 1.75 1.36 2.27 1.66 × 10−5
Female Sex 0.98 0.68 1.42 0.929 Female Sex 1.02 0.67 1.55 0.942 Female Sex 1.52 0.90 2.55 0.116
Coronary Artery Calcified Plaque 1.67 1.24 2.26 7.18 × 10−4 Coronary Artery Calcified Plaque 1.60 1.15 2.23 0.005 Coronary Artery Calcified Plaque 1.40 0.98 2.00 0.067
Urine Albumin: creatinine Ratio 1.52 1.32 1.75 7.59 × 10−9 Urine Albumin: creatinine Ratio 1.57 1.35 1.83 7.31 × 10−9 Urine Albumin: creatinine Ratio 1.45 1.24 1.70 3.29 × 10−6
History of Cardiovascular Disease 1.69 1.11 2.57 0.014 History of Cardiovascular Disease 1.52 0.95 2.43 0.084 History of Cardiovascular Disease 1.55 0.98 2.45 0.063
Diabetes Duration 1.20 0.98 1.46 0.082 Diabetes Duration 1.04 0.84 1.28 0.736 Diabetes Duration 1.09 0.88 1.36 0.435
      C-reactive Protein 1.19 0.93 1.51 0.167 Biventricular Volume 1.52 1.16 1.98 0.002
  1. The cardiovascular disease mortality model was selected using a two-fold cross-validation approach in European Americans with type 2 diabetes. Hazards ratios (HRs) are for a one standard deviation change in the predictor (continuous variables) or change in group assignment (dichotomous variables). For medication use HRs, the HRs are for risk of mortality among those individuals using the given medication class